First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
Author:
Affiliation:
1. Department of Dermatology; National Taiwan University Hospital and National Taiwan University College of Medicine; Taipei 10002 Taiwan
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.13633/fullpdf
Reference9 articles.
1. Incidence and mortality of bullous pemphigoid in France;Joly;J Invest Dermatol,2012
2. Mortality of bullous pemphigoid in China;Li;JAMA Dermatol,2013
3. First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus;Cho;Acta Derm Venereol,2014
4. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts;Murrell;J Am Acad Dermatol,2012
5. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients;Kasperkiewicz;J Am Acad Dermatol,2011
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Corticosteroids are still first-line therapies for bullous pemphigoid, with biologics finding use in difficult-to-treat disease;Drugs & Therapy Perspectives;2024-07-05
2. Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein;Journal of Dermatological Science;2024-04
3. Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update;American Journal of Clinical Dermatology;2023-12-29
4. Durability of long-term immunomodulating medications in the treatment of bullous pemphigoid;Journal of the American Academy of Dermatology;2023-12
5. Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches;Clinical Reviews in Allergy & Immunology;2023-10-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3